Trial record 7 of 2326 for:    smoking

Smoking Cessation Invention in the Emergency Department (ED)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ben Heavrin, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01173653
First received: July 29, 2010
Last updated: December 19, 2012
Last verified: December 2012
  Purpose

The emergency department (ED) serves a vital and growing role in the US health care system, responsible for both the delivery of emergent medical care and for safety-net care for populations without traditional access to health services. Uninsured populations rely significantly on the safety-net services of the ED. Between 2000-2005 the number of uninsured Americans increased from 39.6 million to 46.1 million, and this growth is expected to continue. Many health policy analysts consider the ED to be an effective place to provide preventative care. Prophylactic tetanus immunization, for example, has been a successful preventive health intervention that has become a standard of care in the ED setting. Brief smoking cessation interventions have been introduced in the ED but have not had great success based on lack of follow-up and continuity.

Our study is novel in that it introduces a brief smoking intervention through use of an established, federally-funded and federally-sponsored cessation counseling resource, the National Smoking Cessation Quit Line, also available at smokefree.gov. This is a joint initiative between the Tobacco Control Research Branch of the National Cancer Institute and the Centers for Disease Control and Prevention. Since ED patients who smoke often lack the ability to use self-help cessation resources, we hypothesize that by introducing this population to the counselors on the National Smoking Cessation Quit Line (also called the 1-800-QUIT-NOW line) during the ED visit via phone, that this new brief intervention would have a realizable and significant effect on smoking cessation among the this population.


Condition Intervention
Smoking Cessation
Tobacco Use Cessation
Health Behavior
Other: Smoking Cessation

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: A Randomized Controlled Trial of Directed Smoking Cessation Intervention in the Emergency Care Population

Resource links provided by NLM:


Further study details as provided by Vanderbilt University:

Primary Outcome Measures:
  • Smoking Status at Follow up [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Patients enrolled in this study were contacted via phone to assess smoking status. Smoking status was a self-report from each subject. Primary outcome measure is the smoking status of the enrollee at the time of follow-up contact. We calculated the percentage of participants who had stopped smoking at the 6 week follow-up period in each arm


Enrollment: 199
Study Start Date: July 2010
Study Completion Date: January 2011
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Standard EM Smoking Cessation Info
Patients discharged from ER receive pamphlet re: smoking cessation
Other: Smoking Cessation
Randomly introducing patients to a Department of Health program to help them quit smoking.
Active Comparator: Patients contact 1-800-QUIT-NOW before leaving ED
Prior the patient leaving the ED, the PI will assist the patient with contacting 1-800-QUIT-NOW, who will help patient to quit smoking.
Other: Smoking Cessation
A simple intervention where ED patients who were motivated to quit smoking were put in direct phone contact with a trained smoking cessation counselor during their ED stay.

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients 18 years of age and older
  • Patients who are active smokers who present to the Adult ED at VUMC
  • Patients who are able to give informed verbal consent
  • Patients with stable vital signs

Exclusion Criteria:

  • Patients who are unable to provide consent
  • Patients who are unable to communicate verbally as determined by the treating attending physician and/or triage nurse. This includes patients with alterations in mental status, who are cognitively impaired, or are intoxicated or on drugs
  • Patients with abnormal vital signs, and triage ratings (ES1 score 1) suggesting immediate life threatening illness
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01173653

Locations
United States, Tennessee
Vanderbilt University Medical Center - Emergency Medicine
Nashville, Tennessee, United States, 37232-4700
Sponsors and Collaborators
Vanderbilt University
Investigators
Principal Investigator: Ben Heavrin, MD Vanderbilt University
  More Information

No publications provided

Responsible Party: Ben Heavrin, Benjamin S. Heavrin, MD, MBA, Vanderbilt University
ClinicalTrials.gov Identifier: NCT01173653     History of Changes
Other Study ID Numbers: 100411
Study First Received: July 29, 2010
Results First Received: January 9, 2012
Last Updated: December 19, 2012
Health Authority: United States: Food and Drug Administration

Keywords provided by Vanderbilt University:
smoking
smoking cessation
health behavior

Additional relevant MeSH terms:
Emergencies
Smoking
Tobacco Use Disorder
Disease Attributes
Pathologic Processes
Habits
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014